Boris Johnson speaks at COVID-19 press briefing

The UK excels in genomic sequencing, allowing it to identify new strains effectively. The chief medical officer has shared findings with the WHO, maintaining transparency. While the new variant spreads faster, it is not more lethal, nor does it affect vaccine efficacy. Research continues to enhance understanding, but immediate action is necessary.

What advantage does the UK have in identifying new strains of viruses?

• It has the largest number of scientists.

• It has the best genomic sequencing ability.

• It has the highest funding for research.

• It has the most advanced laboratories.

What has the UK done with its findings on the new variant?

• Published them in a scientific journal.

• Shared them with the World Health Organization.

• Kept them confidential.

• Sent them to other countries for verification.

What is known about the transmission of the new variant?

• It is not transmitted at all.

• It is transmitted more quickly.

• It is transmitted more slowly.

• It is transmitted at the same rate as other variants.

Is there evidence that the new variant is more lethal?

• No, there is no evidence of increased lethality.

• Yes, it is more lethal.

• No, it is less lethal.

• Yes, it causes more severe illness.

What is the current understanding of the vaccine's effectiveness against the new variant?

• The vaccine is less effective.

• The vaccine is more effective.

• The vaccine's effectiveness remains unchanged.

• The vaccine is ineffective.